Elsevier
Journal of Autoimmunity
,  volume 149 ,  pages 103326

Regulatory B cells in autoimmune diseases: Insights and therapeutic potential

Qin-Yi Su 1
, 
Zhong-Qing Jiang 2, 3
, 
Zhongqing Jiang 4
, 
Xuan-Yi Song 2, 3
, 
Xinqiang Song 4
, 
Sheng-Xiao Zhang 2, 3, 5, 6
, 
Shengxiao Zhang 7
1
 
2
 
Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Shanxi Province, Taiyuan, China | 
3
 
4
 
5
 
6
 
7
 
Publication type: Journal Article
Publication date: 2024-12-01
Elsevier
scimago Q1
wos Q1
SJR: 2.281
CiteScore: 13.6
Impact factor: 7.0
ISSN: 08968411, 10959157
Abstract
Autoimmune diseases are characterized by the body's immune system attacking its own cells, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). In recent studies, regulatory B cells (Bregs), which play a vital role in maintaining peripheral tolerance and controlling persistent autoimmune diseases (ADs), have shown great potential in treating ADs. This review synthesizes the latest advancements in targeted therapies for ADs, with a particular emphasis on the subgroups, phenotypic markers, and signal pathways associated with Bregs. Following an examination of these elements, the discussion pivots to innovative Breg-based therapeutic approaches for the management of ADs.
Found 
Found 

Top-30

Journals

1
Food Bioscience
Food Bioscience, 1, 20%
Food Bioscience
1 publication, 20%
Frontiers in Immunology
Frontiers in Immunology, 1, 20%
Frontiers in Immunology
1 publication, 20%
Nature reviews. Rheumatology
Nature reviews. Rheumatology, 1, 20%
Nature reviews. Rheumatology
1 publication, 20%
Cells
Cells, 1, 20%
Cells
1 publication, 20%
Gut Microbes
Gut Microbes, 1, 20%
Gut Microbes
1 publication, 20%
1

Publishers

1
Elsevier
Elsevier, 1, 20%
Elsevier
1 publication, 20%
Frontiers Media S.A.
Frontiers Media S.A., 1, 20%
Frontiers Media S.A.
1 publication, 20%
Springer Nature
Springer Nature, 1, 20%
Springer Nature
1 publication, 20%
MDPI
MDPI, 1, 20%
MDPI
1 publication, 20%
Taylor & Francis
Taylor & Francis, 1, 20%
Taylor & Francis
1 publication, 20%
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
5
Share
Cite this
GOST |
Cite this
GOST Copy
Su Q. et al. Regulatory B cells in autoimmune diseases: Insights and therapeutic potential // Journal of Autoimmunity. 2024. Vol. 149. p. 103326.
GOST all authors (up to 50) Copy
Su Q., Jiang Z., Jiang Z., Song X., Song X., Zhang S., Zhang S. Regulatory B cells in autoimmune diseases: Insights and therapeutic potential // Journal of Autoimmunity. 2024. Vol. 149. p. 103326.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.jaut.2024.103326
UR - https://linkinghub.elsevier.com/retrieve/pii/S0896841124001604
TI - Regulatory B cells in autoimmune diseases: Insights and therapeutic potential
T2 - Journal of Autoimmunity
AU - Su, Qin-Yi
AU - Jiang, Zhong-Qing
AU - Jiang, Zhongqing
AU - Song, Xuan-Yi
AU - Song, Xinqiang
AU - Zhang, Sheng-Xiao
AU - Zhang, Shengxiao
PY - 2024
DA - 2024/12/01
PB - Elsevier
SP - 103326
VL - 149
PMID - 39520834
SN - 0896-8411
SN - 1095-9157
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Su,
author = {Qin-Yi Su and Zhong-Qing Jiang and Zhongqing Jiang and Xuan-Yi Song and Xinqiang Song and Sheng-Xiao Zhang and Shengxiao Zhang},
title = {Regulatory B cells in autoimmune diseases: Insights and therapeutic potential},
journal = {Journal of Autoimmunity},
year = {2024},
volume = {149},
publisher = {Elsevier},
month = {dec},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0896841124001604},
pages = {103326},
doi = {10.1016/j.jaut.2024.103326}
}